Advanced drug delivery systems in cancer chemotherapy

Disease Management and Clinical Outcomes

Volumn 3, Issue 2, 2001, Pages 48-54

  Minko, T ^a   Dharap, S S ^a   Pakunlu, R I ^a   Colaizzi, J L ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTISENSE OLIGODEOXYNUCLEOTIDE; DOXORUBICIN; LIPOSOME; MICROSPHERE; PROTEIN BCL 2;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CELL DEATH; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG MECHANISM; DRUG RELEASE; HUMAN; MULTIDRUG RESISTANCE; NONHUMAN; PROTEIN DOMAIN;

EID: 0034770839     PISSN: 10883371     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Diagnostics of multidrug resistance in cancer
2. The ABC family of multidrug transporters in microorganisms
3. Novel chemically modified oligonucleotides provide potent inhibition of P-glycoprotein expression
4. Inhibition of P-glycoprotein and recovery of drug sensitivity of human acute leukemic blast cells by multidrug resistance gene (mdr1) anti-sense oligonucleotides
5. An oligomer complementary to the 5′ end region of MDR1 gene decreases resistance to doxorubicin of human adenocarcinoma-resistant cells
6. Comparison of the anti-cancer effect of free and HPMA copolymer-bound adriamycin in human ovarian carcinoma cells
7. Efficacy of the chemotherapeutic action of HPMA copolymer-bound doxorubicin in a solid tumor model of ovarian carcinoma
8. Role of the BCL-2 gene family in prostate cancer progression and its implications for therapeutic intervention
9. BCL-2 family members and the mitochondria in apoptosis
10. Dysregulation of apoptosis in cancer
11. Apoptosis in cancer
12. Mcl-1 - Just another antiapoptotic BCL-2 homolog
13. Preliminary evaluation of caspase-dependent apoptosis signaling pathways of free and HPMA copolymer-bound doxorubicin in human ovarian carcinoma cells
14. Mechanisms of anti-cancer action of HPMA copolymer-bound doxorubicin
15. Chronic exposure to HPMA copolymer bound adriamycin does not induce multidrug resistance in a human ovarian carcinoma cell line
16. A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent SMANCS
17. Rituximab: The first monoclonal antibody approved for the treatment of lymphoma
18. The EGF receptor family as targets for cancer therapy
19. HPMA copolymer-anticancer drug conjugates: Design, activity, and mechanism of action
20. Water soluble polymers in tumor targeted delivery
21. Anti-TNF therapy and malignancy - A critical review
22. Innovative treatments for pancreatic cancer
23. Technology evaluation: SGN-15, Seattle Genetics Inc.
24. Polymer conjugates for tumor targeting and intracytoplasmic delivery. The EPR effect as a common gateway?
25. Preclinical toxicology of a novel polymeric antitumor agent: HPMA copolymer-doxorubicin (PK1)
26. Chimaeric Lym-1 monoclonal antibody-mediated cytolysis by neutrophils from G-CSF-treated patients: Stimulation by GM-CSF and role of Fc gamma-receptors
27. Expression of tumor-associated glycoprotein-72 (TAG-72) antigen in human prostatic adenocarcinomas
28. 6 conjugates and a preliminary study of their photodynamic effect on mouse splenocytes in vitro
29. Regulation of apoptosis by BH3 domains in a cell-free system
30. Role of the BH3 (BCL-2 homology 3) domain in the regulation of apoptosis and BCL-2-related proteins
31. Bak BH3 peptides antagonize BCL-XL functions and induce apoptosis through cytochrome c-independent activation of caspases
32. Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3
33. Clinical studies of antisense therapy in cancer
34. Liposomal Bcl-2 antisense oligonucleotides enhance proliferation, sensitize acute myeloid leukemia to cytosine-arabinoside, and induce apoptosis independent of other antiapoptotic proteins
35. The influence of cytotoxicity of macromolecules and of VEGF gene modulated vascular permeability on the enhanced permeability and retention effect in experimental resistant solid tumor
36. HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. 3. The effect of free and polymer-bound adriamycin on the expression of some genes in the OVCAR-3 human ovarian carcinoma cell line
37. HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line